Skip to main content
Livermore
Livermore
ZHEN

Redmile Group, LLC

SEC CIK
0001425738
Latest filing
Aug 14, 2026

RPTX holding history

Repare Therapeutics Inc. in every 13F filed by Redmile Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RPTX overviewAll 13F holders of RPTXFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of RPTX by Redmile Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−1,586,174−100.0%Sold outHolders
Q4 20251,586,174$4.12M0.3%00.0%UnchangedHolders
Q3 20251,586,174$2.79M0.3%00.0%UnchangedHolders
Q2 20251,586,174$2.20M0.2%−298,215−15.8%ReducedHolders
Q1 20251,884,389$1.86M0.2%−31,700−1.7%ReducedHolders
Q4 20241,916,089$2.51M0.2%−26,466−1.4%ReducedHolders
Q3 20241,942,555$6.68M0.4%00.0%UnchangedHolders
Q2 20241,942,555$6.41M0.4%−73,747−3.7%ReducedHolders
Q1 20242,016,302$9.50M0.3%−132,446−6.2%ReducedHolders
Q4 20232,148,748$15.7M0.6%−255,947−10.6%ReducedHolders
Q3 20232,404,695$29.0M1.4%−23,640−1.0%ReducedHolders
Q2 20232,428,335$25.7M1.0%−104,715−4.1%ReducedHolders
Q1 20232,533,050$24.9M1.1%−151,346−5.6%ReducedHolders
Q4 20222,684,396$39.5M1.6%00.0%UnchangedHolders
Q3 20222,684,396$32.6M1.3%−36,600−1.3%ReducedHolders
Q2 20222,720,996$38.1M1.5%−12,000−0.4%ReducedHolders
Q1 20222,732,996$38.9M1.2%−56,500−2.0%ReducedHolders
Q4 20212,789,496$58.8M1.3%+221,800+8.6%AddedHolders
Q3 20212,567,696$67.4M1.2%−56,700−2.2%ReducedHolders
Q2 20212,624,396$81.8M1.2%−41,100−1.5%ReducedHolders
Q1 20212,665,496$81.8M1.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.